Electromed, Inc. (ELMD) |
| 28.13 0.14 (0.5%) 01-14 13:13 |
| Open: | 27.61 |
| High: | 28.18 |
| Low: | 27.61 |
| Volume: | 12,081 |
| Market Cap: | 235(M) |
| PE Ratio: | 29.93 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 30.49 |
| Resistance 1: | 29.15 |
| Pivot price: | 28.45 |
| Support 1: | 26.98 |
| Support 2: | 22.45 |
| 52w High: | 35.56 |
| 52w Low: | 17.73 |
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Fri, 19 Dec 2025
Electromed Enters New Senior Secured Revolving Credit Facility - The Globe and Mail
Thu, 18 Dec 2025
Electromed Signs Credit Agreement With BMO Bank - TradingView — Track All Markets
Mon, 01 Dec 2025
3 Reasons Why Growth Investors Shouldn't Overlook Electromed (ELMD) - Yahoo Finance
Thu, 20 Nov 2025
Electromed, Inc. to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference - TMX Newsfile
Fri, 14 Nov 2025
Is Electromed (ELMD) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Fri, 14 Nov 2025
Electromed (ELMD) Upgraded to Buy: Here's Why - Nasdaq
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |